VINORELBINE AG vinorelbine (as tartrate) 50 mg/5 mL concentrated injection vial

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

vinorelbine tartrate, Quantity: 69.25 mg (Equivalent: vinorelbine, Qty 50 mg)

Verfügbar ab:

MedTAS Pty Ltd

INN (Internationale Bezeichnung):

Vinorelbine tartrate

Darreichungsform:

Injection, concentrated

Zusammensetzung:

Excipient Ingredients: water for injections

Verabreichungsweg:

Intravenous Infusion

Einheiten im Paket:

Pack of 1 x 5 mL vial, Pack of 5 x 5 mL vials, Pack of 10 x 5 mL vials

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

Treatment of advanced breast cancer after failure of standard therapy, as a single agent or in combination; and as a first line treatment for advanced non-small cell lung cancer, as a single agent or in combination.

Produktbesonderheiten:

Visual Identification: Clear solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2012-01-18